BUSINESS BITES: Sinocare Grows US Biz; Valeritas Finally Goes Public; Cytosystems Nabs EU Grant; B+L, IBM Eye New App
This article was originally published in Clinica
Executive Summary
Sinocare, China’s largest manufacturer of budget-end blood glucose monitoring systems is expanding its presence in the US with the proposed acquisition of Indiana-based PTS Diagnostics. PTS supplies point-of-care biometric testing devices, including the CardioChek family of blood lipid analyzers, A1CNow systems for blood glucose and PTS Detect cotinine systems. Its products are sold entirely through distributors in over 135 countries.